Lisdexamfetamine Dimesylate (Vyvanse) for the Treatment of Neurogenic Anejaculation

Lisdexamfetamine Dimesylate (Vyvanse) for the Treatment of Neurogenic Anejaculation

Bibliographic Details
Main Authors:	Matthew D. Lyons MD, Aaron C. Lentz MD, Robert M. Coward MD
Format:	Article
Language:	English
Published:	SAGE Publishing 2017-05-01
Series:	American Journal of Men's Health
Online Access:	https://doi.org/10.1177/1557988316658640

Similar Items

Traumatic Brain Injury-Related Attention Deficits in Children: A Controlled Treatment Trial with Lisdexamfetamine Dimesylate (Vyvanse)
by: Michael G. Tramontana, et al.
Published: (2021-01-01)

Impulsivity and Its Relationship With Lisdexamfetamine Dimesylate Treatment in Binge Eating Disorder
by: Kristi R. Griffiths, et al.
Published: (2021-08-01)

Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine
by: Michael Pennick
Published: (2010-06-01)

Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder
by: Jadwiga Najib, et al.
Published: (2017-08-01)

Antioxidant effect of simvastatin throught oxidative imbalance caused by lisdexamfetamine dimesylate
by: Guilherme A. Eger, et al.
Published: (2016-03-01)

Treatment outcomes after methylphenidate in adults with attention-deficit/hyperactivity disorder treated with lisdexamfetamine dimesylate or atomoxetine
by: Joseph A, et al.
Published: (2016-03-01)

Secondary outcomes and qualitative findings of an open-label feasibility trial of lisdexamfetamine dimesylate for adults with bulimia nervosa
by: Laura Dixon, et al.
Published: (2023-05-01)

Long‐term study of lisdexamfetamine dimesylate in Japanese children and adolescents with attention‐deficit/hyperactivity disorder
by: Hironobu Ichikawa, et al.
Published: (2020-03-01)

Correction: Secondary outcomes and qualitative findings of an open-label feasibility trial of lisdexamfetamine dimesylate for adults with bulimia nervosa
by: Laura Dixon, et al.
Published: (2023-11-01)

Influence of Lisdexamfetamine Dimesylate on Early Ejaculation—Results from a Double-Blind Randomized Clinical Trial
by: Mohammad Haghighi, et al.
Published: (2021-07-01)

Understanding the neural mechanisms of lisdexamfetamine dimesylate (LDX) pharmacotherapy in Binge Eating Disorder (BED): a study protocol
by: Kristi R. Griffiths, et al.
Published: (2019-07-01)

Efficacy of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder previously treated with methylphenidate: a post hoc analysis
by: Jain Rakesh, et al.
Published: (2011-11-01)

Clinical response and symptomatic remission in short- and long-term trials of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder
by: Mattingly Greg W, et al.
Published: (2013-01-01)

Double-blind, placebo-controlled, two-period, crossover trial to examine the pharmacokinetics of lisdexamfetamine dimesylate in healthy older adults
by: Ermer J, et al.
Published: (2013-02-01)

Single Dose Comparative Bioavailability Study of Lisdexamfetamine Dimesylate as Oral Solution Versus Reference Hard Capsules in Healthy Volunteers
by: Simona Rizea-Savu, et al.
Published: (2022-04-01)

Post hoc analyses of the impact of previous medication on the efficacy of lisdexamfetamine dimesylate in the treatment of attention-deficit/hyperactivity disorder in a randomized, controlled trial
by: Coghill DR, et al.
Published: (2014-10-01)

Efficacy and tolerability of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: sex and age effects and effect size across the day
by: Childress Ann C, et al.
Published: (2010-12-01)

The effects of lisdexamfetamine dimesylate on eating behaviour and homeostatic, reward and cognitive processes in women with binge-eating symptoms: an experimental medicine study
by: Elizabeth Schneider, et al.
Published: (2022-01-01)

Development, validation and comparison of two stability-indicating RP-LC methods using charged aerosol and UV detectors for analysis of lisdexamfetamine dimesylate in capsules
by: Graciela Carlos, et al.
Published: (2016-11-01)

Analysis of individual items on the attention-deficit/hyperactivity disorder symptom rating scale in children and adults: the effects of age and sex in pivotal trials of lisdexamfetamine dimesylate
by: Weisler RH, et al.
Published: (2013-12-01)

Acute anejaculation, hypogonadism, and fertility preservation in the setting of neurosarcoidosis: case report and literature review
by: Benjamin Yu, B.A., et al.
Published: (2020-12-01)

Predictors of anejaculation after Aquablation procedure for BPH
by: D-D. Nguyen, et al.
Published: (2020-07-01)

Situational psychogenic anejaculation: A case study
by: Rajesh Gopalakrishnan, et al.
Published: (2014-01-01)

Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: novel findings using a simulated adult workplace environment design
by: Gao Joseph, et al.
Published: (2010-06-01)

A phase 1, randomized, double‐blind, placebo‐controlled study to evaluate the safety, tolerability, and pharmacokinetics of single and multiple doses of lisdexamfetamine dimesylate in Japanese and Caucasian healthy adult subjects
by: James Ermer, et al.
Published: (2020-03-01)

Congenital urethral diverticulum in an adult male patient presenting with anejaculation
by: Kholoud Alabassi, et al.
Published: (2023-09-01)

Physician perception of clinical improvement in children with attention-deficit/hyperactivity disorder: a post hoc comparison of lisdexamfetamine dimesylate and mixed amphetamine salts extended release in a crossover analog classroom study
by: L&oacute;pez F, et al.
Published: (2011-05-01)

Lisdexamfetamine Toxicity with Delayed Hypertensive Emergency
by: Rachel Schult, et al.
Published: (2017-12-01)

Lisdexamfetamine in the treatment of adolescents and children with attention-deficit/hyperactivity disorder
by: Najib J
Published: (2012-05-01)

Takotsubo Cardiomyopathy Due to Combined Use of Phentermine and Lisdexamfetamine
by: Tara Burleigh, et al.
Published: (2020-08-01)

Low-frequency neuromuscular electrical stimulation as a treatment for anejaculation caused by iatrogenic injury of the abdominal aorta: a case study
by: Kefan Li, et al.
Published: (2023-10-01)

Pharmacokinetics and Pharmacodynamics of Lisdexamfetamine Compared with D-Amphetamine in Healthy Subjects
by: Patrick C. Dolder, et al.
Published: (2017-09-01)

Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD
by: Maneeton N, et al.
Published: (2014-10-01)

Association between serotonin transporter 5-HTTLPR and STin2 VNTR polymorphisms and anejaculation: a preliminary report
by: Yuan-Yuan Huang, et al.
Published: (2017-01-01)

Trial protocol of an open label pilot study of lisdexamfetamine for the treatment of acute methamphetamine withdrawal
by: Liam S. Acheson, et al.
Published: (2022-01-01)

Trial protocol of an open label pilot study of lisdexamfetamine for the treatment of acute methamphetamine withdrawal.
by: Liam S Acheson, et al.
Published: (2022-01-01)

Rise, and pronounced regional variation, in methylphenidate, amphetamine, and lisdexamfetamine distribution in the United States
by: Sneha M. Vaddadi, et al.
Published: (2021-12-01)

New and extended-action treatments in the management of ADHD: a critical appraisal of lisdexamfetamine in adults and children
by: Diana Domnitei, et al.
Published: (2010-05-01)

Use of Lisdexamfetamine to Treat Obesity in an Adolescent with Severe Obesity and Binge Eating
by: Gitanjali Srivastava, et al.
Published: (2019-02-01)

Intercourse type of situational anejaculation or inability to ejaculate intra-vaginally: three case reports from a conservative islamic community
by: Oguzhan Bekir Egilmez, et al.
Published: (2018-10-01)